Kinfo
GlucoTrack Inc. logo

GlucoTrack Inc.

GCTKNASDAQHealthcare·US · USD
$1.10
-0.05 (-4.35%)
Prices as of October 8, 2026 · live

Price

Key statistics

Valuation
Market cap1.17M USD
Enterprise value1.63M USD
Trailing P/E0.07
Forward P/E0.00
PEG ratio-0.00
Price / sales0.00
Price / book-3.16
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-164.45%
Return on equity-620.63%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA-15.33M USD
Net income-15.95M USD
Diluted EPS-$123.15
Rev. growth (YoY)0.00%
Balance sheet
Total cash1.12M USD
Total debt1.96M USD
Debt / equity-1.13
Current ratio0.46
Book value / share-$4.17
Cash flow (TTM)
Operating cash flow-16.22M USD
Levered free cash flow-10.39M USD
Shares & price
Shares outstanding6.56M
Float636.24K
Held by institutions12.19%
Beta0.73
50-day MA$4.02
200-day MA$16.71
52-week high$125.25
52-week low$1.07
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-130.440.50+13.64%2026-01-080.070.10+42.86%2025-09-240.010.04+300.00%
About GlucoTrack Inc.

GlucoTrack Inc. is a medical technology company focused on diabetes monitoring solutions. GlucoTrack Inc. develops devices and systems designed to measure blood glucose levels for people living with diabetes, with an emphasis on continuous monitoring and reduced reliance on traditional finger-stick testing. Its current work centers on non-invasive glucose monitoring technology and an investigational long-term implantable continuous blood glucose monitor intended for ongoing glycemic tracking. The company’s products and development programs are aimed at supporting patients with Type 1 diabetes, insulin-dependent Type 2 diabetes, and prediabetes, while also serving clinicians who manage these conditions. GlucoTrack Inc. operates within the healthcare equipment and medical device market, where glucose monitoring tools play a critical role in daily diabetes care and disease management. The company is headquartered in Rutherford, New Jersey.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Erik C. Emerson
Employees
15
Headquarters
Rutherford, NJ, United States

Frequently asked questions about GlucoTrack Inc.